Additional studies involving human primary breast tumor tissues and/or pertinent cell lines provide a detailed understanding of the regulation of ESR1 and its correlation to specific lncRNAs and miRNAs for more targeted therapies for BCs, especially for the prevention and/or treatment of the most prevalent hormone-dependent subtype. The gene discussed is ESR1; the disease is breast neoplasm.